covid
Buscar en
Revista Colombiana de Anestesiología
Toda la web
Inicio Revista Colombiana de Anestesiología Anestesia general para cesárea. Papel del sugammadex en la calidad y la segurid...
Journal Information
Vol. 40. Issue 1.
Pages 75-78 (January - March 2012)
Share
Share
Download PDF
More article options
Vol. 40. Issue 1.
Pages 75-78 (January - March 2012)
Open Access
Anestesia general para cesárea. Papel del sugammadex en la calidad y la seguridad del acto anestésico. Reporte de caso
General Anesthesia for C-Section. The Role of Sugammadex in the quality and safety of anesthesia. Case Report
Visits
7467
Luis Alberto Tafur Ba,
Corresponding author
tafur05@hotmail.com

Autor para correspondencia: Carrera 1F # 58-50 apto 303A, Cali, Colombia.
, Eduardo Lema Flórezb
a Anestesiólogo, Hospital Universitario del Valle Evaristo García, Clínica Salud Florida, Profesor asistente, Universidad del Valle, Cali, Colombia
b Anestesiólogo, Hospital Universitario del Valle Evaristo García, Profesor asistente, Universidad del Valle, Cali, Colombia
This item has received

Under a Creative Commons license
Article information
Resumen

La cesárea es una de las intervenciones quirúrgicas más realizadas en el planeta. En el 5% de los casos se practica bajo anestesia general (7,5 millones de anestesias generales para cesárea cada año). Debido a sus requerimientos particulares (paciente con estómago lleno, necesidad de relajación neuromuscular, bienestar del binomio madre-hijo, expectativas de pronta atención del recién nacido por parte de la madre y relativa corta duración del procedimiento) la anestesia general representa un reto en cada intervención. En este artículo se presenta el caso de una mujer gestante que requirió anestesia general para una cesárea de urgencia. Se utilizó rocuronio como relajante neuromuscular y se obtuvo un acceso rápido a la vía aérea, así como condiciones quirúrgicas adecuadas. Al final se revirtió el procedimiento con sugammadex a dosis de 1mg/kg. El surgimiento de nuevos agentes para la reversión de la relajación neuromuscular contribuye a un manejo seguro durante el acto anestésico; además, estos agentes disminuyen la probabilidad de relajación residual y permiten un mejor control del tiempo y de la profundidad de la relajación. Los estudios sugieren dosis de sugammadex que muy probablemente cambiarán con el advenimiento de nuevos estudios, haciéndolas ajustables al grado de relajación neuromuscular que se tenga, lo cual ayudará a disminuir los costos y, por lo tanto, a aumentar la disponibilidad del medicamento en nuestros quirófanos.

Palabras clave:
Anestesia general
Cesárea
Anestesia
Agentes bloqueadores neuromusculares
Abstract

C-section is one of the most common surgical procedures in the world, with 5% of the cases being managed under general anesthesia (7.5 million C-sections performed under general anesthesia every year). Due to its special circumstances (i.e., the patient has a full stomach, need for neuromuscular relaxation, mother-child wellbeing, the mother is expected to immediately provide care to the baby, and the procedure takes a short time), general anesthesia is a challenge in every case. This article discusses the case of a pregnant woman who required general anesthesia for an emergency C-section. The neuromuscular relaxant used was Rocuronium. The airway was secured promptly and the surgical conditions were appropriate. The procedure was finally reversed with sugammadex at a dose of 1mg/kg. The availability of new neuromuscular relaxation reversal agents contributes to safe management during anesthesia; furthermore, these agents limit the chances of a residual relaxation and allow better time control and depth of relaxation. Studies suggest sugammadex doses that will probably change with the advent of new trials, adapting them to the degree of neuromuscular relaxation obtained, and this will help to reduce costs and hence improve the availability of the drug in our ORs.

Keywords:
General anesthesia
Cesarean section
Anesthesia
Neuromuscular blocking agents
Full text is only aviable in PDF
Referencias
[1.]
J.M. Belizán, F. Althabe, F.C. Barros, et al.
Rates and implications of caesarean sections in Latin America: ecological study.
BMJ., 319 (1999), pp. 1397-1400
[2.]
H. King, S. Ashley, D. Brathwaite, et al.
Adequacy of general anesthesia for cesarean section.
Anesth Analg., 77 (1993), pp. 84-88
[3.]
J. Viby-Mogensen, J. Engbaek, L.I. Eriksson, et al.
Good clinical research practice (GCRP) in pharmacodynamic studies of neuro-muscular blocking agents.
Acta Anaesthesiol Scand., 40 (1996), pp. 59-74
[4.]
F. Adnet, S.W. Borron, S.X. Racine, et al.
The intubation difficulty scale (IDS). Proposal and evaluation of a new score characterizing the complexity of endotracheal intubation.
Anesthesiology., 87 (1997), pp. 1290-1297
[5.]
R. Somers, Y. Jacquemyn, L. Sermeus, et al.
Corrected scoliosis, cholinesterase deficiency, and cesarean section: a case report.
Case Report Med., 2009 (2009), pp. 957479
[6.]
J. Guay, Y. Grenier, F. Varin.
Clinical pharmacokinetics of neuromuscular relaxants in pregnancy.
Clin Pharmacokinet., 34 (1998), pp. 483
[7.]
W.W. Andrews, S.M. Ramin, M.C. Maberry, et al.
Effect of type of anesthesia on blood loss at elective repeat cesarean section.
Am J Perinatol., 9 (1992), pp. 197-200
[8.]
España.
Ministerio de Sanidad y Política Social. Estudio IBEAS: Prevalencia de Efectos Adversos en Hospitales de Latinoamérica.
Ministerio de Sanidad y Política Social, (2009),
[9.]
S.A. Abu-Halaweh, I.M. Massad, H.M. Abu-Ali, et al.
Rapid sequence induction and intubation with 1mg/kg rocuronium bromide in cesarean section, comparison with suxamethonium.
Saudi Med J., 28 (2007), pp. 1393-1396
[10.]
G.S. Murphy.
Residual neuromuscular blockade: incidence, assessment, and relevance in the postoperative period.
Minerva Anestesiol., 72 (2006), pp. 97-109
[11.]
B. Plaud, B. Debaene, F. Donati, et al.
Residual paralysis after emergence from anesthesia.
Anesthesiology., 112 (2010), pp. 1013-1022
[12.]
M. Grayling, B.P. Sweeney.
Recovery from neuromuscular blockade: a survey of practice.
Anaesthesia., 62 (2007), pp. 806-809
[13.]
G. Cammu, J. De Witte, J. De Veylder, et al.
Postoperative residual paralysis in outpatients versus inpatients.
Anesth Analg., 102 (2006), pp. 426-429
[14.]
B. Debaene, B. Plaud, M.P. Dilly, et al.
Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action.
Anesthesiology., 98 (2003), pp. 1042-1048
[15.]
M.E. Davis, M.E. Brewster.
Cyclodextrin-based pharmaceutics: past, present and future.
Nat Rev Drug Discov., 3 (2004), pp. 1023-1035
[16.]
Álvarez Gómez JA, et al. Reversal of vecuronium-induced moderate neuromuscular blockade is significantly faster with sugammadex compared with neostigmine. Results from the AURORA trial. Poster presented at the European Society of Anaesthesiology, 9–12 June 2007, Munich, Germany.
[17.]
S.J. Schaller, H. Fink, K. Ulm, et al.
Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block.
Anesthesiology., 113 (2010), pp. 1054-1060
Copyright © 2012. Sociedad Colombiana de Anestesiología y Reanimación
Article options